MedPath

Olink Holding AB

🇸🇪Sweden
Ownership
-
Employees
707
Market Cap
$3.2B
Website
Introduction

Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions.

© Copyright 2025. All Rights Reserved by MedPath